PARA_OA_008 top-line data readout September 2022
• Canine OA model preliminary data readout Q3 CY2022
• PARA_OA_002 Update – First data safety monitoring board review Q4 CY2022
• PARA_OA_006 extension study commencement Q4 CY2022
• FY22 tax rebate Q4 CY2022
• Further IP generation and protection
• MPS-I data presented at International Conference on Lysosomal Diseases Q1 CY2023
• PARA_OA_008 6-month data Q1 CY2023
• Canine OA Model – 20-week follow-up (3-year human equivalent) data
Q1 CY2023
• PARA_OA_002 Stage 1 dose selection 1H CY2023.
• Paradigm is currently in active discussion with multiple potential partners for its Phase 2 asset in Mucopolysaccharidosis (MPS).
PARA_OA_008 top-line data readout September 2022 • Canine OA...
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
24.0¢ |
Change
0.010(4.35%) |
Mkt cap ! $83.95M | |||
| Open | High | Low | Value | Volume |
| 23.5¢ | 24.0¢ | 23.3¢ | $98.72K | 418.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 109736 | 23.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 24.0¢ | 24542 | 5 |
View Market Depth
| Last trade - 14.38pm 14/06/2024 (20 minute delay) ? |
|
|||||
|
Last
23.5¢ |
Change
0.010 ( 2.17 %) |
||||
| Open | High | Low | Volume | ||
| 23.5¢ | 24.0¢ | 23.5¢ | 63626 | ||
| Last updated 14.41pm 14/06/2024 ? | |||||
| PAR (ASX) Chart |